Amphotericin B in a lipid emulsion for the treatment of cryptococcal meningitis in AIDS patients

Journal of Antimicrobial Chemotherapy

Volumn 38, Issue 1, 1996, Pages 117-126

  Joly, V ^a   Geoffray, C ^a   Reynes, J ^b   Goujard, C ^c   Mechali D ^d   Maslo, C ^e   Raffi, F ^f   Yeni, P ^a  

^a BICHAT HOSPITAL   (France)

^b GUI DE CHAULIAC HOSPITAL   (France)

^c HÔPITAL ANTOINE BÉCLÈRE   (France)

^d Hôpital Jean de la Fontaine   (France)

^e HÔPITAL ROTHSCHILD   (France)

^f HÔTEL DIEU   (France)

Author keywords

[No Author keywords available]

Indexed keywords

AMPHOTERICIN B; ANTIFUNGAL AGENT; LIPID EMULSION;

ADULT; AIDS RELATED COMPLEX; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CRYPTOCOCCAL MENINGITIS; CRYPTOCOCCUS NEOFORMANS; DOSE RESPONSE; DRUG EFFECT; HUMAN; MULTICENTER STUDY; TREATMENT OUTCOME;

ADULT; AIDS-RELATED OPPORTUNISTIC INFECTIONS; AMPHOTERICIN B; ANTIBIOTICS, ANTIFUNGAL; CRYPTOCOCCUS NEOFORMANS; DOSE-RESPONSE RELATIONSHIP, DRUG; FAT EMULSIONS, INTRAVENOUS; HUMANS; MENINGITIS, CRYPTOCOCCAL; TREATMENT OUTCOME;

EID: 0030179959     PISSN: 03057453     EISSN: None     Source Type: Journal    
DOI: 10.1093/jac/38.1.117     Document Type: Article

References (21)

1. Armstrong, D. (1993). Treatment of opportunistic fungal infections. Clinical Infectious Diseases 16, 1-7.
2. British Society for Antimicrobial Chemotherapy Working Party (1992). Antifungal chemotherapy in patients with acquired immunodeficiency syndrome. Lancet 340, 648-51.
3. Butler, W. P., Bennett, J. E., Ailing, D. W., Wertlake, P. T., Utz, J. P. & Hill, G. J. (1964). Nephrotoxicity of amphotericin B: early and late effects in 81 patients. Annals of Internal Medicine 61, 175-87.
4. Caillot, D., Casanovas, O., Solary, E., Chavanet, P., Bonnette, B., Reny, G. et al. (1993). Efficacy and tolerance of an amphotericin B lipid (Intralipid) emulsion in the treatment of candidaemia in neutropenic patients. Journal of Antimicrobial Chemotherapy 31, 161-9.
5. Caillot, D., Reny, G., Solary, E., Casasnovas, O., Chavanet, P., Bonnette, B. et al. (1994). A controlled trial of the tolerance of amphotericin B infused in dextrose or in Intralipid in patients with haematologic malignancies. Journal of Antimicrobial Chemotherapy 33, 603-13.
6. Chavanet, P. Y., Garry, I., Charlier, N., Caillot, D., Kisterman, J. P., D'Athis, M. et al. (1992). Trial of glucose versus fat emulsion in preparation of amphotericin for use in HIV-infected patients with candidiasis. British Medical Journal 305, 921-5.
7. Chuck, S. L. & Sande, M. A. (1989). Infections with Cryptococcus neoformans in the acquired immunodeficiency syndrome. New England Journal of Medicine 321, 794-9.
8. Coker, R. J., Viviani, M., Gazzard, B. G., Dupont, B., Pohle, H. D., Murphy, S. M. et al. (1993). Treatment of cryptococcosis with liposomal amphotericin B (AmBisome) in 23 patients with AIDS. AIDS 7, 829-35.
9. Dismukes, W. E. (1993). Management of cryptococcosis. Clinical Infectious Diseases 17, Suppl. 2, S507-12.
10. Gallis, H. A., Drew, R. H. & Pickard, W. W. (1990). Amphotericin B: 30 years of clinical experience. Review of Infectious Diseases 12, 308-29.
11. Graybill, J. R., Sharkey, P. K., Vincent, D., Johnson, E., Fan Havard, P., Eng, R. et al. (1991). Amphotericin B lipid complex (ABLC) in treatment (Rx) of cryptococcal meningitis (CM) in patients with AIDS. In Programm and Abstracts of the Thirty-First Interscience Conference on Antimicrobial Agents and Chemotherapy, Chicago, 1991. Abstract 289, p. 147. American Society for Microbiology, Washington, DC.
12. Joly, V., Farinotti, R., Saint-Julien, L., Cheron, M., Carbon, C. & Yeni, P. (1994). In vitro renal toxicity and in vivo therapeutic efficacy in experimental cryptococcosis of amphotericin B (Fungizone) associated with Intralipid. Antimicrobial Agents and Chemotherapy 38, 177-83.
13. Larsen, R. A., Leal, M. A. E. & Chan, L. S. (1990). Fluconazole compared with amphotericin B plus flucytosine for cryptococcal meningitis in AIDS. A randomized trial. Annals of Internal Medicine 113, 183-7.
14. Millier, M. A. (1984). Reversible hepatotoxicity related to amphotericin B. Canadian Medical Association Journal 131, 1245-7.
15. Moreau, P., Milpied, N., Fayette, N., Ramee, J. F. & Harousseau, J. L. (1992). Reduced renal toxicity and improved clinical tolerance of amphotericin B mixed with intralipid compared with conventional amphotericin B therapy in neutropenic patients. Journal of Antimicrobial Chemotherapy 3, 535-41.
16. Powderly, W. G. (1993). Cryptococcal meningitis and AIDS. Clinical Infectious Diseases 17, 837-42.
17. Powderly, W. G., Saag, M. S., Cloud, G. A., Robinson, P., Meyer, R. D., Jacobson, J. M. et al. (1992). A controlled trial of fluconazole or amphotericin B to prevent relapse of cryptococcal meningitis in patients with the acquired immunodeficiency syndrome. New England Journal of Medicine 326, 793-8.
18. Rozenbaum, R. & Goncalves, A. J. R. (1994). Clinical epidemiological study of 171 cases of cryptococcosis. Clinical Infectious Diseases 18, 369-80.
19. Saag, M. S., Powderly, W. G., Cloud G. A., Robinson, P., Grieco, M. H., Sharkey, P. K. et al. (1992). Comparison of amphotericin B with fluconazole in the treatment of acute AIDS-associated cryptococcal meningitis. New England Journal of Medicine 326, 83-9.
20. Utz, J. P., Bennett, J. E., Brandriss, M. W., Butler, W. T. & Hill, J. G. (discussants). (1964). Amphotericin B toxicity. Annals of Internal Medicine 61, 334-54.
21. Van der Horst, C., Saag, M., Cloud, G., Hamill, R., Graybill, R., Sobel, J. et al. (1995). Randomized double blind comparison of amphotericin B plus flucytosine (AMB + FC) to AMB alone followed by a comparison of fluconazole to itraconazole in the treatment of acute cryptococcal meningitis in patients with AIDS. In Program and Abstracts of the Thirty-Fifth Interscience Conference on Antimicrobial Agents and Chemotherapy, San Francisco, CA, 1995. Abstract I 216, p. 244. American Society for Microbiology, Washington, DC.